These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 27660911)
1. Analysis of enhancement at small and large radiation doses for effectiveness of inactivation in cultured cells by combining two agents with radiation. Franken NA; Kok HP; Crezee J; Barendsen GW Int J Radiat Biol; 2016 Sep; 92(9):521-6. PubMed ID: 27660911 [TBL] [Abstract][Full Text] [Related]
2. Enhancement of radiation effectiveness by hyperthermia and incorporation of halogenated pyrimidines at low radiation doses as compared with high doses: implications for mechanisms. Franken NA; Barendsen GW Int J Radiat Biol; 2014 Apr; 90(4):313-7. PubMed ID: 24460134 [TBL] [Abstract][Full Text] [Related]
3. Enhancement of Radiation Effectiveness in Cervical Cancer Cells by Combining Ionizing Radiation with Hyperthermia and Molecular Targeting Agents. IJff M; van Oorschot B; Oei AL; Krawczyk PM; Rodermond HM; Stalpers LJA; Kok HP; Crezee J; Franken NAP Int J Mol Sci; 2018 Aug; 19(8):. PubMed ID: 30115874 [TBL] [Abstract][Full Text] [Related]
4. Cell survival and radiosensitisation: modulation of the linear and quadratic parameters of the LQ model (Review). Franken NA; Oei AL; Kok HP; Rodermond HM; Sminia P; Crezee J; Stalpers LJ; Barendsen GW Int J Oncol; 2013 May; 42(5):1501-15. PubMed ID: 23503754 [TBL] [Abstract][Full Text] [Related]
5. The nucleo-shuttling of the ATM protein as a basis for a novel theory of radiation response: resolution of the linear-quadratic model. Bodgi L; Foray N Int J Radiat Biol; 2016; 92(3):117-31. PubMed ID: 26907628 [TBL] [Abstract][Full Text] [Related]
6. Radiosensitization by bromodeoxyuridine and hyperthermia: analysis of linear and quadratic parameters of radiation survival curves of two human tumor cell lines. Franken NA; Van Bree C; Veltmaat MA; Rodermond HM; Haveman J; Barendsen GW J Radiat Res; 2001 Jun; 42(2):179-90. PubMed ID: 11599884 [TBL] [Abstract][Full Text] [Related]
7. Substructure in the radiation survival response at low dose in cells of human tumor cell lines. Skarsgard LD; Skwarchuk MW; Wouters BG; Durand RE Radiat Res; 1996 Oct; 146(4):388-98. PubMed ID: 8927711 [TBL] [Abstract][Full Text] [Related]
8. Characterization of in vitro radiosensitization in mammalian cells using biomathematical modelling: implications for hypofractionated radiotherapy with a combined modality approach. Seo Y; Tamari K; Yoshioka Y; Isohashi F; Suzuki O; Hayashi K; Takahashi Y; Baek S; Otani K; Ogawa K Br J Radiol; 2016 Jun; 89(1062):20150724. PubMed ID: 26975496 [TBL] [Abstract][Full Text] [Related]
9. On the analysis of clonogenic survival data: Statistical alternatives to the linear-quadratic model. Unkel S; Belka C; Lauber K Radiat Oncol; 2016 Jan; 11():11. PubMed ID: 26822015 [TBL] [Abstract][Full Text] [Related]
10. Importance of cell proliferative state and potentially lethal damage repair on radiation effectiveness: implications for combined tumor treatments (review). Barendsen GW; Van Bree C; Franken NA Int J Oncol; 2001 Aug; 19(2):247-56. PubMed ID: 11445835 [TBL] [Abstract][Full Text] [Related]
11. Hyperthermia and incorporation of halogenated pyrimidines: radiosensitization in cultured rodent and human tumor cells. Van Bree C; Franken NA; Bakker PJ; Klomp-Tukker LJ; Barendsen GW; Kipp JB Int J Radiat Oncol Biol Phys; 1997 Sep; 39(2):489-96. PubMed ID: 9308955 [TBL] [Abstract][Full Text] [Related]
12. BrdUrd-induced radiosensitization of two human tumour cell lines at iso-levels of incorporation. Franken NA; Van Bree C; Kipp JB; Rodermond HM; Haveman J; Barendsen GW Oncol Rep; 2000; 7(5):937-40. PubMed ID: 10948317 [TBL] [Abstract][Full Text] [Related]
13. Can drugs enhance hypofractionated radiotherapy? A novel method of modeling radiosensitization using in vitro data. Ohri N; Dicker AP; Lawrence YR Int J Radiat Oncol Biol Phys; 2012 May; 83(1):385-93. PubMed ID: 22265460 [TBL] [Abstract][Full Text] [Related]
14. Extending the linear-quadratic model for large fraction doses pertinent to stereotactic radiotherapy. Guerrero M; Li XA Phys Med Biol; 2004 Oct; 49(20):4825-35. PubMed ID: 15566178 [TBL] [Abstract][Full Text] [Related]
15. Hypoxic cell sensitization: low-dose intrinsic radiosensitivity is predictive for etanidazole efficacy in a panel of human tumour cell lines. Wouters BG; Sy AM; Skarsgard LD Int J Radiat Biol; 1996 Dec; 70(6):719-33. PubMed ID: 8980670 [TBL] [Abstract][Full Text] [Related]
16. Compatibility of the linear-quadratic formalism and biologically effective dose concept to high-dose-per-fraction irradiation in a murine tumor. Otsuka S; Shibamoto Y; Iwata H; Murata R; Sugie C; Ito M; Ogino H Int J Radiat Oncol Biol Phys; 2011 Dec; 81(5):1538-43. PubMed ID: 22115556 [TBL] [Abstract][Full Text] [Related]
17. New insights into factors influencing the clinically relevant oxygen enhancement ratio. Daşu A; Denekamp J Radiother Oncol; 1998 Mar; 46(3):269-77. PubMed ID: 9572620 [TBL] [Abstract][Full Text] [Related]
18. Effects of oxygen on intrinsic radiation sensitivity: A test of the relationship between aerobic and hypoxic linear-quadratic (LQ) model parameters. Carlson DJ; Stewart RD; Semenenko VA Med Phys; 2006 Sep; 33(9):3105-15. PubMed ID: 17022202 [TBL] [Abstract][Full Text] [Related]
19. A track-event theory of cell survival. Besserer J; Schneider U Z Med Phys; 2015 Jun; 25(2):168-75. PubMed ID: 25432332 [TBL] [Abstract][Full Text] [Related]
20. Effect of patient variation on standard- and hypo-fractionated radiotherapy of prostate cancer. Xiong W; Li J; Ma CM Phys Med Biol; 2005 Apr; 50(7):1483-92. PubMed ID: 15798338 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]